泌尿器科領域の悪性腫瘍患者に対するToyomycinの応用
スポンサーリンク
概要
- 論文の詳細を見る
Chromomycin A3, Toyomycin is a new antibiotic for tum o r produced from Streptomyces griseus No. 7. It was found in the soil of Toyonaka city, Osaka, Japan and presented by Research Laboratory of Takeda Pharmaceutical Industries, Co. Ltd.. This antitumorous agent was administered intravenously in 6 cases with inoperable malignancies. In a case with adenocarcinoma of the prostate clinical i m provement was seen, associated with histological regression of carcinoma. Cystourethrography also showed decrease in size of tumor. In remaining 5 cases, however, efficacy was not so remarkable. They were 1 case of neuroblastoma, 2 transitional cell carcinoma of the bladder and 2 renal carcinoma. It is suggested that certain type of neoplasia shows response to this agent. No severe side effect.
- 泌尿器科紀要刊行会の論文
泌尿器科紀要刊行会 | 論文
- MVAC療法後の転移性尿路上皮癌に対するGemcitabine, Docetaxel, Carboplatin併用化学療法の検討
- Grade 3 Ta-1表在性膀胱癌に対する膀胱温存治療
- 腹腔鏡下に摘出した後腹膜神経線維腫の1例
- 移植腎生検による腎内動脈瘤破裂の1例
- Modified M-VAC療法後に残存腫瘍切除を施行した進行尿路上皮癌患者の治療成績